Lexogen, an ambitious new biotech company, is developing a set of complementary technologies that will present a breakthrough in the level of detail that RNA expression can be profiled.
Lexogen's proprietary SQUARETM technology presents a unique, hypothesis-free approach to reduce the complexity of the transcriptome and empowers Next Generation Sequencing technologies to sequence and quantify all splice variants in which genes are expressed. Lexogen's SQUARE technology will provide unprecedented insight in molecular pathways.
SENSETM is an "all-in-one" mRNA-Seq library preparation kit. It resolves the main limitations of existing RNA-Seq library preparation protocols by providing an unprecedented level of strand-specificity. The almost complete elimination of ribosomal RNA allows robust analysis of mRNA and does not require any extra enrichment and purification kits.
In addition, Lexogen is developing new technologies for the targeted analysis of defined transcripts of interest.